Enhancing Diagnostic Precision: Characterizing Subgroup Variability Within WHO Group 3 Pulmonary Hypertension Using ICD-10 Code I27.23 and Manual EHR ReviewRichard Green, Rajeev Saggar, S. Arora et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 0
PHocus: a global Phase 2 study of inhaled mosliciguat in pulmonary hypertension associated with interstitial lung disease (PH-ILD)Hossein Ardeschir Ghofrani, Marc Humbert, Rogério Souza et al.|Unknown|2025Cited by 0